Concepedia

Disha Rao

DR

Statistics

Publications

6

Citations

2.8K

H-Index

6

Active since

2020

Affiliations

Oncode Institute(Current)

The Netherlands Cancer Institute

Leiden University Medical Center

Dutch Cancer Society

The University of Sydney

Disha Rao is an author at Oncode Institute specializing in immunotherapy, cancer immunotherapy, and oncology.

ORCID

Publications per year

2020–2023

6

Publications

6

B cells and tertiary lymphoid structures promote immunotherapy response

Beth A. Helmink, Sangeetha M. Reddy, Jianjun Gao et al. · Nature · 2020 · 2.7K citations · Full text

, , +16

IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma

Irene L. M. Reijers, Disha Rao, Judith M. Versluis et al. · The Journal of Experimental Medicine · 2023 · 74 citations · Full text

, , +17

Acidity‐mediated induction of FoxP3 <sup>+</sup> regulatory T cells

Disha Rao, Johanna A. Stunnenberg, Ruben Lacroix et al. · European Journal of Immunology · 2023 · 29 citations · Full text

, , +17

Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells

Esmée P. Hoefsmit, Paula T. van Royen, Disha Rao et al. · Cancer Immunology Research · 2023 · 17 citations

, , +17

IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 mutation

Elisa A. Rozeman, Judith M. Versluis, Karolina Sikorska et al. · Journal for ImmunoTherapy of Cancer · 2023 · 15 citations · Full text

, , +17

1–5 of 6